EMT and Treatment Resistance in Pancreatic Cancer von Gaianigo, Nicola, Melisi, Davide, Carbone, Carmine

Volltext

Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study von Abou-Alfa, Ghassan K, Sahai, Vaibhav, Hollebecque, Antoine, Vaccaro, Gina, Melisi, Davide, Al-Rajabi, Raed, Paulson, Andrew S, Borad, Mitesh J, Gallinson, David, Murphy, Adrian G, Oh, Do-Youn, Dotan, Efrat, Catenacci, Daniel V, Van Cutsem, Eric, Ji, Tao, Lihou, Christine F, Zhen, Huiling, Féliz, Luis, Vogel, Arndt

Volltext

Clinicogenomic Analysis of FGFR2 -Rearranged Cholangiocarcinoma Identifies Correlates of Response and Mechanisms of Resistance to Pemigatinib von Silverman, Ian M, Hollebecque, Antoine, Friboulet, Luc, Owens, Sherry, Newton, Robert C, Zhen, Huiling, Féliz, Luis, Zecchetto, Camilla, Melisi, Davide, Burn, Timothy C

Volltext

Angiopoietin-Like Proteins in Angiogenesis, Inflammation and Cancer von Carbone, Carmine, Piro, Geny, Merz, Valeria, Simionato, Francesca, Santoro, Raffaela, Zecchetto, Camilla, Tortora, Giampaolo, Melisi, Davide

Volltext

Permissive State of EMT: The Role of Immune Cell Compartment von Fedele, Vita, Melisi, Davide

Volltext

Outcomes of Primary Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma von Maggino, Laura, Malleo, Giuseppe, Marchegiani, Giovanni, Viviani, Elena, Nessi, Chiara, Ciprani, Debora, Esposito, Alessandro, Landoni, Luca, Casetti, Luca, Tuveri, Massimiliano, Paiella, Salvatore, Casciani, Fabio, Sereni, Elisabetta, Binco, Alessandra, Bonamini, Deborah, Secchettin, Erica, Auriemma, Alessandra, Merz, Valeria, Simionato, Francesca, Zecchetto, Camilla, D’Onofrio, Mirko, Melisi, Davide, Bassi, Claudio, Salvia, Roberto

Volltext

Prognostic Impact of Preoperative Nutritional Risk in Patients Who Undergo Surgery for Pancreatic Adenocarcinoma von Trestini, Ilaria, Paiella, Salvatore, Sandini, Marta, Sperduti, Isabella, Elio, Giovanni, Pollini, Tommaso, Melisi, Davide, Auriemma, Alessandra, Soldà, Caterina, Bonaiuto, Clelia, Tregnago, Daniela, Avancini, Alice, Secchettin, Erica, Bonamini, Deborah, Lanza, Massimo, Pilotto, Sara, Malleo, Giuseppe, Salvia, Roberto, Bovo, Chiara, Gianotti, Luca, Bassi, Claudio, Milella, Michele

Volltext

TAK-ing aim at chemoresistance: The emerging role of MAP3K7 as a target for cancer therapy von Santoro, Raffaela, Carbone, Carmine, Piro, Geny, Chiao, Paul J., Melisi, Davide

Volltext

Homeobox B9 Mediates Resistance to Anti-VEGF Therapy in Colorectal Cancer Patients von Carbone, Carmine, Piro, Geny, Simionato, Francesca, Ligorio, Francesca, Cremolini, Chiara, Loupakis, Fotios, Alì, Greta, Rossini, Daniele, Merz, Valeria, Santoro, Raffaela, Zecchetto, Camilla, Zanotto, Marco, Di Nicolantonio, Federica, Bardelli, Alberto, Fontanini, Gabriella, Tortora, Giampaolo, Melisi, Davide

Volltext

Pathologic angiogenesis in the bone marrow of humanized sickle cell mice is reversed by blood transfusion von Park, Shin-Young, Matte, Alessandro, Jung, Yookyung, Ryu, Jina, Anand, Wilson Babu, Han, Eun-Young, Liu, Min, Carbone, Carmine, Melisi, Davide, Nagasawa, Takashi, Locascio, Joseph J., Lin, Charles P., Silberstein, Leslie E., De Franceschi, Lucia

Volltext

Safety and activity of the TGFβ receptor I kinase inhibitor galunisertib plus the anti-PD-L1 antibody durvalumab in metastatic pancreatic cancer von Melisi, Davide, Oh, Do-Youn, Hollebecque, Antoine, Calvo, Emiliano, Varghese, Anna, Borazanci, Erkut, Macarulla, Teresa, Merz, Valeria, Zecchetto, Camilla, Zhao, Yumin, Gueorguieva, Ivelina, Man, Michael, Gandhi, Leena, Estrem, Shawn T, Benhadji, Karim A, Lanasa, Mark C, Avsar, Emin, Guba, Susan C, Garcia-Carbonero, Rocio

Volltext

KRAS wild-type pancreatic ductal adenocarcinoma: molecular pathology and therapeutic opportunities von Luchini, Claudio, Paolino, Gaetano, Mattiolo, Paola, Piredda, Maria L, Cavaliere, Alessandro, Gaule, Marina, Melisi, Davide, Salvia, Roberto, Malleo, Giuseppe, Shin, Jae Il, Cargnin, Sarah, Terrazzino, Salvatore, Lawlor, Rita T, Milella, Michele, Scarpa, Aldo

Volltext

Pancreatic Cancer and Obesity: Molecular Mechanisms of Cell Transformation and Chemoresistance von Cascetta, Priscilla, Cavaliere, Alessandro, Piro, Geny, Torroni, Lorena, Santoro, Raffaela, Tortora, Giampaolo, Melisi, Davide, Carbone, Carmine

Volltext

Targeting KRAS: The Elephant in the Room of Epithelial Cancers von Merz, Valeria, Gaule, Marina, Zecchetto, Camilla, Cavaliere, Alessandro, Casalino, Simona, Pesoni, Camilla, Contarelli, Serena, Sabbadini, Fabio, Bertolini, Monica, Mangiameli, Domenico, Milella, Michele, Fedele, Vita, Melisi, Davide

Volltext

Modulation of Pancreatic Cancer Chemoresistance by Inhibition of TAK1 von Melisi, Davide, Xia, Qianghua, Paradiso, Genni, Ling, Jianhua, Moccia, Tania, Carbone, Carmine, Budillon, Alfredo, Abbruzzese, James L., Chiao, Paul J.

Volltext

Integration of liposomal irinotecan in the first-line treatment of metastatic pancreatic cancer: try to do not think about the white bear von Melisi, Davide, Casalino, Simona, Pietrobono, Silvia, Quinzii, Alberto, Zecchetto, Camilla, Merz, Valeria

Volltext

Mechanisms of resistance to chemotherapeutic and anti-angiogenic drugs as novel targets for pancreatic cancer therapy von Tamburrino, Anna, Piro, Geny, Carbone, Carmine, Tortora, Giampaolo, Melisi, Davide

Volltext

LY2109761, a novel transforming growth factor β receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis von Melisi, Davide, Ishiyama, Satoshi, Sclabas, Guido M, Fleming, Jason B, Xia, Qianghua, Tortora, Giampaolo, Abbruzzese, James L, Chiao, Paul J

Volltext

Induction of immunosuppressive functions and NF-κB by FLIP in monocytes von Fiore, Alessandra, Ugel, Stefano, De Sanctis, Francesco, Sandri, Sara, Fracasso, Giulio, Trovato, Rosalinda, Sartoris, Silvia, Solito, Samantha, Mandruzzato, Susanna, Vascotto, Fulvia, Hippen, Keli L., Mondanelli, Giada, Grohmann, Ursula, Piro, Geny, Carbone, Carmine, Melisi, Davide, Lawlor, Rita T., Scarpa, Aldo, Lamolinara, Alessia, Iezzi, Manuela, Fassan, Matteo, Bicciato, Silvio, Blazar, Bruce R., Sahin, Ugur, Murray, Peter J., Bronte, Vincenzo

Volltext

A phase II trial of the FGFR inhibitor pemigatinib in patients with metastatic esophageal–gastric junction/gastric cancer trastuzumab resistant: the FiGhTeR trial von Merz, Valeria, Zecchetto, Camilla, Simionato, Francesca, Cavaliere, Alessandro, Casalino, Simona, Pavarana, Michele, Giacopuzzi, Simone, Bencivenga, Maria, Tomezzoli, Anna, Santoro, Raffaela, Fedele, Vita, Contarelli, Serena, Rossi, Irene, Giacomazzi, Serena, Pasquato, Martina, Piazzola, Cristiana, Milleri, Stefano, de Manzoni, Giovanni, Melisi, Davide

Volltext